Several recent observations suggest that successful rearrangement of the T cell receptor (TCR) B locus reduces several important events in thymocyte maturation. Allelic exclusion is achieved by interruption of further rearrangement of the ~/locus, and CD4-8-mterleukln (IL)-2R + cells enter the CD4 +8 + IL-2R-stage. The actual molecular events regnlatmg this important control point are unknown, but may be related to the expression of the TCR-B locus in immature CD4-8-thymocytes. It is not clear whether maturation is induced by intracellular appearance of TCR-B chain or by signal transductlon through an immature TCR complex on the thymocyte membrane, possibly involving TCR-/~ chain homodimers and CD3. Here we show that early ad&tion of anti-CD3 mAb to fetal thymic organ cultures induces all known events associated with the acqmsitlon of the CD4 + 8 + stage. Expression of CD4 and CD8 is accelerated, IL-2RoL is downregnlated, and the cells fail to produce TCR-B, possibly based on premature cessation of ~ gene rearrangement. Upon stimulation with anti-CD3 antibodies, we see calcinm mobilization m 15% of all CD4-8-thymocytes with no detectable surface TCR expression. These results suggest that functional CD3 is expressed on immature thymocytes at very low concentrations before the appearance of a complete TCR-~/chain. Llgation of CD3 at this stage may mimic the maturauon signal normally generated by the immature TCR-B homochmer-CD3 complex. The results are consistent with the notion that acquisition of the CD4+8 + stage involves signal transduction through an immature TCR complex. Later in thymocyte development, ligatlon of CD3 results in deleuon of CD4 + 8 + cells. Thus, signal transduction through CD3 may result m entirely different cellular responses, depending on the stage of thymocyte differentiation. These results suggest an involvement of CD3 as a hnk m signal transduction for at least two different decision points m the development of a thymocyte.
T
he T lymphocyte lineage is generated from precommitted bone marrow-derived precursor cells that home to the thymus where they enter into a complex developmental program of sequential gene expression and TCR gene rearrangements. Early events include expression of the heat-stable antigen (HSA) 1 (1), followed by the ol chain of the IL-2 receptor (IL-2Ro 0 (2, 3). TCR-B chain rearrangement also takes place at this early stage of thymocyte development. Completion of the rearrangement of the B locus is indicated by the appearance of full-length/~ mRNA and is accompanied by loss of IL-2Rc~ and expression of small amounts of CD4 and CD8 (4, 5) . Strong evidence exasts that rearrangement of the B locus is critical for the transition to the stage characterized by expression of CD4 and CD8 and loss of IL-2Rc~ 1Abbrewaons used In tfits paper DN, double-negative, DP, double-posture, FCM, flow cytometry, FTOC, fetal thymlc organ culture, HSA, heatstable antigen, IC, mtracellular, S, surface (6) (7) (8) . This transition does not take place unless m the presence of an intact thymic environment (9) . The actual differenuation signals required for further maturation at this important control point in thymocyte development are unknown. The CD4b81~ -thymocytes will then mature into the CD4 +8 + double-positive (DP) stage (10) . The TCR-c~ genes complete their rearrangement at tbas stage, the ol~/CD3-TCR is expressed on the cell surface and selection events may now occur. Those thymocytes possessing a TCR that is able to interact with self-MHC are rescued from cell death, a process called positive selection. Negative selection involves deleuon of self-reacting thymocytes by means of apoptosis (11) (12) (13) . The small percentage of cells that survive positive and negative selectmn increase their TCR expression, lose HSA, and develop into mature CD4 + single-positive or CD8 + single-positive T cells.
In vivo and in v~tro, negative selection of DP thymocytes can be induced by antibodies directed against the TCR. For example, addition of anti-CD3 or anti-TCR-~ chain antibodies to fetal thymic organ cultures (FTOC) can cause deletion of DP TCR + cells by apoptosis (14) . However, we and others found that deletion of DP cells by anti-CD3 mAb treatment of FTOC is dependent on the time point of addition (15) . In this study, we show that deletion takes place upon delayed addition, but not upon immediate addition of anti-CD3 mAb to day 14 FTOC. In contrast, early addition of anti-CD3 mAb induces accelerated transition of CD4-8-IL-2R + cells to the CD4 +8 + IL-2R-stage, and blocks TCR45 chain production. These data suggest that signaling through CD3, probably complexed with TCIk-~ chain, regulates transiuon of CD4-8-IL-2R + cells to the DP stage possibly associated with cessation of TCR-B chain gene rearrangement. In addition, our data suggest that during development CD3e can be expressed on the cell surface of thymocytes in the absence of the TCR-B chain.
Materials and Methods
Mzce. FTOC. Fetal thymlc lobes were prepared from BALB/c mice at day 14 ofgestauon They were cultured for various time periods on filter discs floating on I ml of IMDM supplemented w~th 10% selected FCS, 1% glutamm, and 1% kanamycm m 12-well dishes (Costar Corp, Cambridge, MA) at 37~ in 7% CO2/alr, similar to the method ofJenkmson et al. (21) , as prewously described (22) When lobes were cultured with anubo&es, the lobes were suspended for 2 h m medium supplemented with anu-CD3 mAb (145-2Cll if not otherwise stated) or antl-TCE-~ mAb, and thereafter placed on filter discs floating on the same medium unul analysis Exposure to antibo&es was started e~ther at the begmnmg of culture or after various time intervals, as indicated with each experiment If not otherwise stated, cultured were terminated on day 9 for analysis. Addmon of irrelevant hamster IgG to FTOC at 100 /~g/ml did not show any effect on a/~ T cell development compared to FTOC grown m medium without antibo&es Therefore, control lobes were treated in the same way using medium w~thout antibody Smgle cell suspensions were prepared and incubated for 6-8 h at 37~ to allow shedding of bound antibodies (23) Flow Cytometry Two-and three-color stammgs were performed using FITC-, PE-, and biotin-labeled antibodies. As a third color, Tncolor-con3ugated Streptavidm (Medac, Hamburg, FKG) was used Intracellular stamings were performed as described (24) , modified to allow two-color combmed lntraceUular (IC) and surface (S) stammgs. First, thymocytes were incubated with FITClabeled antibodies as indicated above. After washing, unlabeled anubodles of the same kind as used for staining the IC antigen were added to block binding of the labeled anubodles to structures expressed on the cell surface After incubation and washing, Northern Blot Analym. FTOC were cultured for 9 d m the absence or presence of 100 ~g/ml anti CD3 mAb. Cells were isolated and total RNA was prepared as described (25) , except that the protease &gesuon step was omitted Samples were denaturated in the presence of ethldmm bromide. RNA gels were prepared as described (26) 
Results
Early Addition of Anti-CD3 mAb to FTOC Inhibits TCR Expression on CD4 + 8 + DP Thymocytes. Thymic lobes from day 14 embryos were cultured for 9 d and analyzed by flow cytometry. 100/~g/ml of either anti-CD3 mAb or anti-TCR-B chain mAb were added to the cultures at day 0 or 6 of culture. Representauve absolute cell numbers recovered from FTOC treated in this way are given in Table 1 . A triple-staining experiment monitoring expression of CD4 and CD8 and of TCR-fl chain within the CD4+8 + population upon antibody treatment on day 6 is shown in Fig. I , A-F. Both antibodies induce partial deletion of the TCR expressing DP subset. As described earlier, the anti-CD3 mAb has the stronger deleting capacity (29) . Fig. 1 , G-J shows the effects of the addition of the same antibodies on day 0. Under these proporttons of different thymocyte subsets upon antibody treatment of FTOC gaven m percentage of total FTOC were treated at 0 or day 6 of culture with antlbo&es to TCR-B or CD3 Control FTOC were cultured m medium without antlbo&es Cells were analyzed by FCM on day 9 of culture In&cated are uncorrected percentages conditions treatment with antl-TCR-/~ mAb also &minishes the CD4+8+V/3 § subset. In contrast, treatment with antl-CD3 mAb does not change the proportion of DP cells but leads to disappearance of TCR expression in this population. (Fig.  2 C) . Upon surface expression, the concentration of intracellular/~ chain drops slightly. In thymocytes derived from ex VlVO newborn thymus, we find a similar expression of intracellular B chain in the different subsets (Fig. 2 , B and D) Differences are only found in the proportions of the populations. Intracellular CD3 is found m 85-95% of all thymocytes. As seen for TCR-/3 chain, the concentration of lntracellular CD3 drops upon surface expression of the TCR (data not shown).
Expression of lntracellular TCR-~ Chain in Thymocyte Sub

Early Addition of Anti-CD3 mAb to FTOC Leads to Loss oflntracellular~ Chain.
Organ cultures treated at day 0 with 100 #g/ml of mAb were examined, and representative original results are given in Fig. 3 . In Table 1 , the calculated proportions of the most prominent thymocyte subsets are summarized. Anti-TCK-/~ treatment leads to decreased numbers of CD4 + (Fig. 3, A and B) and CD8 § cells (see Fig. 1 ). Whereas the propomons of calls expressing TCR on the surface (V/~S) is strongly diminished (Fig. 3, D and E) , intracellular B chain expression is not affected by the anti-TCK-B treatment. This is shown by the unchanged ratios of V~IC + to V/3IC-cells within the CD4 + population (Fig. 3, A and B) and within the V/3S-population (Fig. 3, D and E) surviving the anti-TCK-~ treatment. In contrast, the antl-CD3 mAb induces a decrease of intracellular ~ chain in all subpopulations. It is surprising that even the VflS-VBIC § subset is strongly &tarnished, implying that calls on which no surface TCK is detected by flow cytometry are affected by anti-CD3 mAb. IntraceUular CD3 expression remains unchanged, accounting for the increase in the CD3S-CD3IC + subset (Table 1) . Similar results were obtained upon treatment of FTOC with the mAb 500A2, a mAb that binds to a different epitope of the CD3e chain (30) . This excludes the possibility that the effects observed are due to erossreactivity of one antl-CD3e mAb with an unknown structure on thymocytes. Table 1 also summarizes thymocyte subsets determined by the same protocols upon adding the antibodies to day 6 of culture. Under these conditions, both anti-TCK-~ and antl-CD3 antibodies induce deletion of the TCK + DP population, as described above.
Dose-Response Kineacs of the Effect of Anti-CD3 Antibodies.
Optimal downregulation of TCK-~ chain was obtained by 100/zg/ml of anti-CD3 mAb, a rather high concentration of roAb. We were therefore worried that nonspecific effects of Ig or the small degree of dilution of the culture media contributed to the effect. We therefore tested a series of other Igs at 100/~g/ml, including normal hamster IgG, normal rat IgG, anti-IL-2Ro~ (rat IgG), anti-TCR-~ (hamster IgG), and anti-PGP-1 (rat IgG). None of these resulted m the disappearance of TCR-~ chain m DP thymocytes (data not shown). Furthermore, a dose-response analysis was performed, using concentrations of anti-CD3 mAb between 1 and 100 #g/ml (Fig. 4) . We observe a nearly linear relationship between the antibody dose and the sizes of the VBIC-CD8 + and V~IC-CD4 § populations. We have also determined, m a different protocol, the degree of saturation of CD3 epltopes by these antibody concentrations. Saturation is reached between 30 and 100 #g/ml. We conclude that anti-CD3 mAb is effective at all concentrations, the maxlmal response being reduced at doses that saturate all available CD3e molecules.
Time Course of B Chain Shut.down by Anti-CD3 mAt~
The almost complete loss of intracellular ~ chain in all cell populations suggested that the shut-down of B chain production by hgatlon of CD3 takes place before or at the onset of chain expression To study this question, we performed time course experiments, adding the antibody at different days of culture and examining the lobes at day 9. In Fig. 5 we show that addition up to day 2 (7 d before analysis) results m constant proportions of CD4 + and CD8 + cells devoid of intracellular ~/chain Thereafter, B chain shut-down m CD4 +8 + cells decreases and is gradually replaced by a deletional response until day 6. This indicates that shut-down of B chain is inducible until 6-7 d before the thymocytes leave the DP stage, which is at the C D 4 -8 -I b 2 E + stage, as can be deduced from the kinetics studies performed by Pearse et al. (4) .
Predominance of Short (1.0 kb) TCR-~ Chain Transc@ts in
Anti-CD3 mAb Treated FTOC. We examined expression of TCR-cx and -~ genes by Northern blot analysis (Fig. 6) . A significant difference in TCR-B mRNA is observed between anti-CD3 treated and control FTOC. In the control FTOC, the full-length 1.3-kb (VDJC) transcript of the TCR-~ genes is clearly detectable, together with very low amounts of the truncated 1.0-kb (JC or DJC) message. In contrast, m antl-CD3 treated cultures we see a dramatic reduction of the fulllength B mRNA and strongly increased expression of the truncated transcript. If~ chain shut-down occurred by transcriptional downregulation we would expect a reduction in full-length mRNA and an unchanged or slightly decreased expression of truncated mRNA. The increased level of truncated ~ mRNA suggests that interruption of ~ chain rearrangement before V-D joining is the cause of B chain shutdown. Hybridization with the Cc~ probe showed full-length (VJC) 1.6-kb c~ gene transcripts in antl-CD3 mAb treated and control cultures. A short, 1.3-kb (JC) transcript is barely detectable. Since hybridization with a ol-actin probe indicated about 2.5 times more mRNA in the antl-CD3 mAb treated FTOC, TCE-o~ chain mRNA appears to be diminished. We do not know whether this corresponds to expenmental variation or reflects a downregulation of c~ chain transcription, possibly caused by the mahlity to express the o~ chain on the cell surface. Because we do not find a predominance of the truncated c~ chain transcript in the antl-CD3 mAb treated FTOC, we do not expect rearrangement of the o~ locus to be inhibited. (Fig. 7, E and C) , and confirm that CD4 appears after CD8 (Fig 7, A and E) . 
7, B, D, F, and/-/). In another experiment we included the analysis of IL-2Ro~ cham m addition to CD4 and CD8 (Fig 8). We find that accelerated acqmsltion of CD4 and CD8
is accompanied by downregulatlon of II~2Rol chain expression. Because downregulation of IL-2RoL seemed only shghtly accelerated compared to control FTOC, the results could be due to exper|mental variation. Therefore we repeated the experiment using FTOC derived from SCID mice, in which development is blocked at the IL-2Rc~ ~ stage. Slgnahng through CD3 is expected to restore the blocked maturation instead of only accelerating normal development. Over 60% of thymocytes derived from untreated SCID-FTOC express Ib2Rc~ (Fig. 9 A) . The population showing a low surface Day of Addition IL-2Rc~ expression of Ib2Rc~ is also found in the recombmase activation gene (RAG)-2-deficient mouse (8) . Treatment with antl-CD3 mAb indeed leads to an almost complete loss of IL-2Rc~ expression (Fig. 9 B) . These results reveal that/3 chain shutdown is not the only consequence of early ligation of CD3e in thymocytes. Rather, a complete developmental program is initiated which reflects the maturation steps typically observed upon the acquisition of the DP stage.
Calcium Mobiliza,on Can Be Induced by An,-CD3 mAb m Day 16 Embryonic DN TCR-Thymocytes. It Is generally
accepted that small concentrations of CD3 may be detected on the surface of thymocytes as soon as CD8 is expressed (31). If we assume that our findings are induced by a direct interaction between the antibody and the affected cell, CD3 can transduce a signal even before expression of CD8. To test this hypothesis, we analyzed the capabihty of DN TCRcells derived from ex wvo thymuses from 16-d-old embryos to mobihze CF + upon hgation of CD3 The data depicted m Fig. 10 , C and D show that indeed Ca z + can be mobv hzed in 15% of these cells. The response was, however, weaker and shorter than described for mature T cells (32) . Thus far, we have no xnformauon on whether the immature thymocytes that respond to anti-CD3 mAb with Ca 2 § mobilization are identical with those that respond by 3 chain shut-down. Antibodies to TCR-3,/# did not induce Ca 2 + mobilization m this cell population (Fig. 10, A and B) , excluding that the response is nonspeclfically reduced by a high concentrauon of hamster IgG. These results suggest that CD3e is expressed at low levels m a proportion of DN TCR-immature thymocytes and represents a functional component in signaling events leading to transition from the DN to the DP stage 9
Discussion
Although the developmental sequence of the phenotypes of thymocytes is well described, little is known about the molecular events that drwe these cells into each subsequent stage of maturation 9 An important control point m thymic development is the transiuon of CD4-8-IL-2R + thymocytes to the CD4+8+IL-2R -stage. Several reports show that were isolated from embryos of day 16 gestauonai age and loaded with Indo-1 Subsequently, the cells were stained for CD4, CD8, TCR-B and -6 using antlbo&es free of azlde at 4~ Gating was for cells negative for all markers. Cells were sumulated at time 0 (arrow) wxth 50 ~g/ml antlboches to CD3 (C, D) or TCR-$ (.4, B) A and C gave the course of the vaolet/blue ratio, which *s hnear to the mohmty of mobdxzed mtracelhlar Ca 2+, over tune B and D show the percentage a0o of cells exposing a concentration of mtracellular Ca 2 + above the background level over time successful rearrangement and expression of the TCR-B chain plays a critical role in this process. Some years ago it was shown that in SCID mice transgemc for a rearranged TCRlocus, thymocytes regained the ability to enter the CD4 + 8 + stage (6) . However, normal numbers of DP cells were only found in SCID mice transgenic for both rearranged ot and ~ loci. Recent results demonstrated that disrupuon of eithor RAG-1 (7) or RAG-2 (8) blocks development at the CD4-8-IL-2R + stage. An arrest in thymocyte development at this point is also found in mice with a disrupted TCIk-B locus, in which the very small numbers of CD4 + 8 + cells are suspected to belong to the 3'/~ lineage. (P. Mombaerts, personal communication). Mice devoid of TCR-c~ chain, m contrast, show normal numbers of DP thymocytes (33) From these experiments it can be deduced that the complete rearrangement of the B locus is an important prerequisite for further maturation of the ot/~ lineage. This finding cannot be attributed to lntracellular events alone, because the transplantation of normal bone marrow cells into SCID mice gave rise to both donor-derived TCR + thymocytes and hostderived CD4 § 8 + TCR-SCID thymocytes (34) . Recent experiments show that immature thymocytes may express a TCR complex consisting of/3-B homodimers in association with CD3. A TCIk complex consisting of a B-/~ chain homodimer, weakly assocaated with CD3, was detected by Punt et al. (35) on a transformed CD4-8 + thymocyte. A TCIk complex consisting of a B-~ homodimer, tightly bound to CD3~ and CD3e, but weakly associated with CD3~" and CD33' was found on SCID T cell lines transfected with a rearranged TCR-~ locus (36) . It has been suggested that signals generated upon surface expression of this complex induces the expression of the coreceptors CD4 and CD8 and possibly also leads to allehc exclusion, an event that is a consequence of an interruption of TCR-~ chain rearrangement (37) Our findings show that most known events associated with the acquisition of the DP stage can be induced by early treatment of FTOC with anti-CD3e mAb" CD4 and CD8 expression is induced on DN thymocytes. Ib2Rot chain expression is downregulated; the cells fail to produce TCR-B chain. The inhibition of the production of TCIk-/~ protein and of full-length TCR-/~ mRNA by antl-CD3 may be caused by the same process that, m the physlologacal situation, results in allelic exclusion, i.e., interrupted rearrangement of TCIk-/~ genes. These findings support the hypothesis that surface expression of and subsequent signal transduction through CD3, perhaps complexed with the TCIk-B chain, may be an important event directing the CD4-8-Ib2R + thymocytes into the next developmental stage. It is not dear, however, whether all of these pheno0rpic changes are part of a single cellular response or just happen to occur simultaneously.
Alternative explanations for shut-off of TCR-/5 production have to be considered. Our findings may reflect a novel kind of negative selection involving transcriptional downregulation of TCR-B chain production. Our time course experiments suggest that the window for inhibition of TCIk-B chain production is open during the CD4-8-IL-2R + stage and may be closed before the TCR-ot locus has fully rearranged (38) . Both a purpose and a pathway for self-tolerance induction at this stage of development are hard to imagane. Furthermore, the mcreased expression of truncated (1.0 kb) TCR-B message is not easily reconciled with a transcriptional shut-off of TCR-~ production Therefore, we favor the hypothesis that a cessation of rearrangement is the cause of impaired TCIk-/3 cham production. Rearrangement of the TCR-ot locus seems unimpaired as can be concluded from the Northern blot analysis showing full-length TCR-c~ mRNA. This is in line with recent experiments indicating that allelic exclusion of the TCR-c~ locus takes place at the DP stage and is dependent on positive selection (39) .
How could rearrangement of the TCIk-~ chain genes be interrupted by hgation of CD3? Owen et al. (15) who observed reduced numbers of Vfl8IC + cells without reduction of CD4 + and CD8 + cells upon antl-CD3 treatment of FTOC, suggested that 3'/~ cells were necessary for rearrangement of the TCR-B locus and that their function was blocked by anti-CD3 mAb. This can be ruled out because recent experiments show that TCR-~-deficient mice can nevertheless rearrange the B locus (P. Mombaerts, personal communication). It is also possible that antl-CD3 antibodies block the interaction of an unknown hgand with CD3 which is required for/~ chain rearrangement to continue to completion. This possibility is unlikely because the blocking of an essential maturanon signal would be expected to result m decreased maturation to DP cells. In our experiments, m contrast, accelerated maturation to the DP stage is observed.
We therefore favor the hypothesis that a signal which m the physiological situation is transduced by CD3 complexed with the B-/~ homodlmer, is delivered prematurely upon hgation of CD3~ molecules before rearrangement of the B locus has finished. This implies that CD3e molecules are expressed on the cell surface of immature thymocytes in the absence of the TCR-/~ chain and are capable of signal transductlon upon crosshnking. This hypothesis is supported by our finding that reduction of CD4 and CD8 and downregulation of IL2Rc~ can be induced in FTOC from SCID mice upon anti-CD3 antibody treatment (manuscript m preparation) The characterization of a thymocyte expressing CD3 on the cell surface in the absence of TCR-ot-, ~-, qr-, or -~ chains (40) , and the recent finding that B-/~ homodlmers are expressed on immature thymocytes (35, 36) suggest that the assembly and surface expression of the TCR complex is differently regulated at early stages of thymocyte development and support the hypothesis that surface expression of a partial TCR complex is important for thymocyte maturation.
Our Ca 2+ mobilization experiments show that a cons,derable number (15%) of DN TCIk-thymocytes derived from embryonic day 16 thymus in fact express functional CD3. It remains to be investigated what the exact phenotype of these cells is. The population appears to be too large to represent immature 3'/c5 cells expressing undetectable concentrations of TCR. Because TCR-c~ message is barely detectable at embryonic day 16 (41) , the population is also too large to represent a subset of thymocytes that has successfully rearranged both the ot and 3 locus and express still un-detectable concentrations of TCR. Therefore, we propose that at least part of ths population is DN thymocytes expressing some CD3 with or without a TCR-/~ chain.
It is interesting how the physiological signals for shutdown of/3 gene rearrangement are generated. A signal may be generated upon formation within the thymocyte membrane of a complex of CD3 with B'/~ homodxmers and perhaps additional molecules. Alternauvely, this complex interacts with a ligand on other cells in the thymus, of epithelial or hematopoetic origin. This latter hypothes~s is attractive because it provides an explanation for the exclusive localization of T cell development to the thymus.
Taken together, these expertments demonstrate that maturation of DN to DP cells, which appears to be dependent on fl chain rearrangement, is a developmental step inducible by signaling through CD3. In addition, the results suggest that CD3e is expressed on the cell surface of developing thymocytes in the absence of a TCR-fl chain. Analysis of the molecular structure of this putative CD3 complex may be of major importance m the understanding of the very early stages of thymocyte development.
